HIKMA FDA Approval ANDA 208773

ANDA 208773

HIKMA

FDA Drug Application

Application #208773

Documents

Letter2020-06-04

Application Sponsors

ANDA 208773HIKMA

Marketing Status

Prescription001

Application Products

001SUSPENSION;ORAL40MG/ML0POSACONAZOLEPOSACONAZOLE

FDA Submissions

UNKNOWN; ORIG1AP2020-05-15STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

HIKMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 208773
            [companyName] => HIKMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"POSACONAZOLE","activeIngredients":"POSACONAZOLE","strength":"40MG\/ML","dosageForm":"SUSPENSION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/15\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/208773Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-05-15
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.